Psychedelic treatment for anorexia nervosa: A first-hand view of how psilocybin treatment did and did not help

Anorexia nervosa (AN) is a psychiatric illness with high mortality rates and limited treatment outcomes. Psilocybin treatment (PT) has shown promise for various mental health indications and there is significant interest in exploring its potential for AN; however, studies to date are preliminary. Given the probable surge in psychedelic studies for AN, more information is needed to understand how to successfully apply and optimize these treatments for this vulnerable population. In this Emerging Topics article, we present a nuanced exploration of the potential benefits and constraints of PT for AN, contextualized within the framework of our clinical findings from a modest phase 1 pilot study. We offer here a synthesis of first-hand experiences and comprehensive thematic insights gleaned from 10 individuals with lived experience, providing a rich tapestry of perspectives on this novel therapeutic approach.

Authors

Institutions

Publication Details

Journal
Psychedelics.
Published
2024-11-07
DOI
https://doi.org/10.61373/pp024e.0034
Citations
1
Primary Topic
Psychedelics and Drug Studies
Type
article
Field-Weighted Citation Impact
0.64
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Psychedelic treatment for anorexia nervosa: A first-hand view of how psilocybin treatment did and did not help

Julie Trim, Stéphanie Knatz Peck, Hannah M. Fisher, Samantha Shao et al.
1 citations
Psychedelics.
Psychedelics and Drug Studies
0.64
article

Psychedelic treatment for anorexia nervosa: A first-hand view of how psilocybin treatment did and did not help

Julie Trim, Stéphanie Knatz Peck, Hannah M. Fisher, Samantha Shao, Walter H. Kaye, Jessie Kim
article en
1 citations

Abstract

Anorexia nervosa (AN) is a psychiatric illness with high mortality rates and limited treatment outcomes. Psilocybin treatment (PT) has shown promise for various mental health indications and there is significant interest in exploring its potential for AN; however, studies to date are preliminary. Given the probable surge in psychedelic studies for AN, more information is needed to understand how to successfully apply and optimize these treatments for this vulnerable population. In this Emerging Topics article, we present a nuanced exploration of the potential benefits and constraints of PT for AN, contextualized within the framework of our clinical findings from a modest phase 1 pilot study. We offer here a synthesis of first-hand experiences and comprehensive thematic insights gleaned from 10 individuals with lived experience, providing a rich tapestry of perspectives on this novel therapeutic approach.

Psychedelics.Vol. 1(1)
University of California San Diego (US)
Good health and well-being
Openalex Percentile: Top 25%
Psychedelics and Drug Studies
0.64
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.